• Core Scientific priced USD 3.3 billion of 7.75% senior secured notes due 2031 at 99.25% of face value.
• Offering expected to close May 6, subject to customary conditions.
• Proceeds earmarked for a debt service reserve account, then distributed to Core Scientific.
• Funds allocated to repay outstanding delayed draw term loans under a previously announced 364-day credit facility, including accrued interest, fees, and expenses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-208905), on May 06, 2026, and is solely responsible for the information contained therein.